Key Points
- The National Healthcare Security Administration (NHSA) found four major pharmacy chains (Yifeng Pharmacy Chain, Laobaixing Pharmacy Chain, Yangtianhe, and Henan Zhangzhongjing Pharmacy) engaged in systemic fraud using medical insurance funds.
- Major violations included swapping cosmetics (huazhuangpin 化妆品) for prescription drugs, misuse of insurance accounts, and excessive prescribing.
- Some pharmacies actively tried to conceal their actions by deleting surveillance footage and destroying accounting ledgers, which the NHSA called “serious in nature and malicious in impact.”
- This fraud often targeted the “pooled fund money”, which is meant for critical medical emergencies, effectively stealing “lifesaving money” from the public.
- The NHSA demands immediate rectification, including internal accountability, comprehensive self-audits, enhanced training, and institutional reforms like a “one-strike” policy for insurance fraud, with follow-up inspections planned.
China’s healthcare system just got a major reality check.
The National Healthcare Security Administration (NHSA) recently cracked down on widespread fraud across multiple pharmacy chains—and the violations they uncovered are pretty shocking.
We’re talking about swapping cosmetics for prescription drugs, deleting surveillance footage to cover tracks, and systematically stealing from the country’s medical insurance fund.
Let’s break down what happened, why it matters, and what comes next for these major retailers.
The Investigation: Unannounced Audits Reveal Systemic Fraud
- Hunan Province: Cities of Huaihua, Shaoyang, Hengyang, and Zhuzhou
- Henan Province: City of Zhengzhou
- Inspection Type: Surprise “Flight Inspections” (unannounced audits)
The NHSA conducted surprise “flight inspections” (unannounced audits) across multiple regions in early 2024.
The target zones included:
- Huaihua, Shaoyang, Hengyang, and Zhuzhou in Hunan Province
- Zhengzhou in Henan Province
The mission was straightforward: find pharmacy chains illegally using medical insurance funds to swap cosmetics (huazhuangpin 化妆品) and other non-medical goods for actual drugs or medical services.
What they found was worse than expected.
Find Top Talent on China's Leading Networks
- Post Across China's Job Sites from $299 / role
- Qualified Applicant Bundles
- One Central Candidate Hub
Your First Job Post Use Checkout Code 'Fresh20'
Four Major Pharmacy Chains Called Out
After the inspections wrapped up, the NHSA summoned senior executives from four major pharmacy chains for regulatory talks:
- Yifeng Pharmacy Chain (Yifeng Yaofang 益丰药房)
- Laobaixing Pharmacy Chain (Laobaixing 老百姓)
- Yangtianhe (Yangtianhe 养天和)
- Henan Zhangzhongjing Pharmacy (Henan Zhangzhongjing Yaofang 河南张仲景)
These aren’t small operations—these are major players in the Chinese pharmacy retail landscape.
The fact that they were all doing this suggests a deeper problem with industry compliance culture.
The Violations: A Breakdown of What Went Wrong
Here’s the thing that makes this investigation particularly damaging: these violations kept happening despite ongoing national crackdowns.
The NHSA had already issued the “Detailed Rules for the Implementation of the Regulations on the Supervision and Administration of the Use of Healthcare Security Funds,” and yet pharmacy chains continued breaking the rules.
Specific Violations Found During Inspections
- Cosmetics-for-Drugs Swaps: Customers could buy cosmetics (huazhuangpin 化妆品) or other commercial goods using their medical insurance cards, then have them recorded as prescription drugs or medical diagnostic services
- Insurance Account Misuse: Violations of real-name medical treatment regulations, allowing people to use insurance cards that weren’t actually theirs
- Excessive Prescribing: Pharmacists writing prescriptions for way more medication than medically necessary
But here’s where it gets really serious.
Evidence Destruction and Cover-Ups
Some pharmacy branches didn’t just break the rules—they actively tried to hide it.
Investigators found that certain locations:
- Transferred evidence to other locations
- Deleted surveillance footage
- Concealed or destroyed accounting ledgers
The NHSA publicly called this out as “serious in nature and malicious in impact.”
Evidence destruction isn’t just a compliance failure—it’s obstruction of justice.
ExpatInvest China
Grow Your RMB in China:
- Invest Your RMB Locally
- Buy & Sell Online in CN¥
- No Lock-In Periods
- English Service & Data
- Start with Only ¥1,000
Why This Matters: Medical Insurance Fraud Explained
You might be wondering: what’s the big deal if someone uses their medical insurance card to buy cosmetics?
The answer comes down to how Chinese healthcare insurance works.
Medical insurance accounts have two types of funds:
- Personal Account Money: Your individual healthcare spending account
- Pooled Fund Money: The collective insurance pool everyone pays into for major medical expenses
The problem: when pharmacies swap cosmetics for drugs, they’re often committing fraud against the pooled fund.
The NHSA emphasized that this pooled medical insurance fund is the “lifesaving money” of the people—it’s meant to cover serious medical emergencies and life-or-death treatments.
When pharmacy chains systematically steal from it, they’re taking money away from people who genuinely need critical care.
Resume Captain
Your AI Career Toolkit:
- AI Resume Optimization
- Custom Cover Letters
- LinkedIn Profile Boost
- Interview Question Prep
- Salary Negotiation Agent
The Penalties: What Happens Now
The NHSA didn’t hold back on consequences.
According to the “Interim Measures for the Management of Designated Retail Pharmacies for Medical Security” (NHSA Order No. 3), here’s what the authorities can and will do:
Immediate Consequences
- Service Agreement Termination: Pharmacies found guilty of swapping goods for medical funds will have their contracts terminated
- Demerit System: Responsible personnel will face a demerit point management system that affects their medical insurance payment qualifications
- External Referrals: Violations outside the NHSA’s jurisdiction will be transferred to relevant departments for prosecution
Translation: these pharmacy chains could lose their ability to accept medical insurance entirely.
That’s a business-ending threat for retail pharmacies.
A Bigger Picture of Systematic Failure
The NHSA’s investigation revealed something more troubling than isolated incidents.
The frequent, professional, and covert nature of these violations across multiple locations suggests:
- Lack of genuine corporate responsibility
- Weak compliance awareness at all levels
- Failed internal controls and oversight systems
These weren’t random mistakes—this was systematic fraud.
The Rectification Demands: Five Requirements for These Pharmacy Chains
The NHSA has given the four pharmacy chains specific requirements to fix this mess.
They need to implement these five changes immediately:
1. Internal Accountability
Strictly hold store managers and responsible individuals accountable for their actions.
The goal: create a strong internal deterrent so employees know fraud carries real consequences.
2. Full Self-Inspection
Conduct a comprehensive self-audit of all designated stores.
Any misused insurance funds must be returned immediately.
In cases involving actual fraud, the chains are encouraged to voluntarily surrender evidence to health security authorities.
3. Warning Education
Use these investigations as real-world lessons to educate all employees on two things:
- The serious consequences of non-compliance
- The importance of brand reputation and trust
4. Specialized Training
Organize mandatory training sessions for all staff focused on:
- Legal regulations governing healthcare security funds
- Service agreement requirements
- Proper procedures for accepting medical insurance
5. Institutional Reform
Strengthen internal compliance systems from the ground up, including:
- Regular oversight of regional and franchised stores
- Implement a “one-strike” policy for any personnel involved in insurance fraud (one violation = automatic firing or removal)
- Better tracking and auditing of transactions across all locations
Follow-Up and Enforcement: The NHSA Isn’t Done
This isn’t a one-time slap on the wrist.
The NHSA has instructed the Healthcare Security Administrations of Hunan and Henan provinces to actively supervise the rectification process.
Additionally, the national body plans to conduct “look-back” follow-up inspections to ensure:
- All risks are actually mitigated
- The pharmacy chains are implementing genuine reforms
- The security of the national medical insurance fund is maintained
Translation: these pharmacy chains are going to be under a microscope for a while.
What This Means for the Industry
This investigation sends a clear message to the entire retail pharmacy industry in China.
The NHSA is serious about protecting medical insurance funds, and major chains can’t hide behind their size or reputation.
For pharmacy chains operating in China, the takeaway is brutal but clear:
- Compliance is non-negotiable. The regulations around medical insurance aren’t suggestions—they’re enforced with termination of business agreements
- Internal controls matter. If your stores are systematically committing fraud, the government will find out and hold leadership accountable
- Reputation damage is real. Being publicly called out by the NHSA damages customer trust and brand value permanently
For investors watching the Chinese healthcare sector, this is a reminder that regulatory risk in pharma retail is very real and can materialize quickly.
The four pharmacy chains facing these violations learned the hard way that swapping cosmetics for drugs might seem like a way to boost sales numbers, but it’s a path to catastrophic regulatory consequences.
